About one in five women diagnosed with breast cancer have too much of a protein called HER2, which makes the cancer more likely to grow faster and return. New research has some good news for women with this cancer.

HER2-positive breast cancer is an aggressive disease that thankfully can be treated with targeted therapies. A new combination regimen was successful in keeping patients in a recent trial disease free.

Myelofibrosis is a type of chronic leukemia that attacks bone marrow. Researchers at Mayo Clinic showed promising study results for one treatment for this disease.

A medication taken off the market in 2010 may have a new use in treating children with an aggressive form of blood cancer.

Patients who have advanced stomach cancer sometimes choose stomach surgery to relieve bleeding and other painful symptoms. That operation may also prolong their lives.

People with type 2 diabetes have higher cancer risks than the general population. The link may have to do with how diabetes affects the metabolism. Diabetes medications may also figure into the equation.

It's never too late to quit smoking, even after a cancer diagnosis, according to recent research.

Lung cancer kills more Americans than colon, breast and prostate cancers combined. And yet there’s no fool-proof way to screen for this disease. Even the most trusted tool sometimes overshoots its mark.

The role inflammation plays in prostate cancer has been debated. Studies have shown inflammation increases and decreases prostate cancer risks. A new study suggests inflammation could be a good sign.

To avoid potentially lethal complications, stem cell transplants had to use cells donated by relatives of the patient or perfectly matched donors. Not anymore. Researchers are expanding the possibilities.